| # | Drug | Count |
|---|---|---|
| 0 | ETANERCEPT | 1076 |
| 1 | DENOSUMAB | 1032 |
| 2 | ADALIMUMAB | 928 |
| 3 | ERGOCALCIFEROL | 662 |
| 4 | METHOTREXATE SODIUM | 661 |
| 5 | ACETAMINOPHEN | 641 |
| 6 | METHOTREXATE | 611 |
| 7 | ASPIRIN | 599 |
| 8 | PREDNISONE | 585 |
| 9 | ASPIRIN 325 MG | 571 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | STANNOUS FLUORIDE | 26 | 0.0728 |
| 1 | BENZOCAINE, MENTHOL | 9 | 0.0588 |
| 2 | POTASSIUM NITRATE AND SODIUM FLUORIDE | 14 | 0.0461 |
| 3 | EUCALYPTOL, MENTHOL, UNSPECIFIED FORM, METHYL SALICYLATE, AND THYMOL | 5 | 0.0265 |
| 4 | DICLOFENAC SODIUM/MISOPROSTOL | 8 | 0.0260 |
| 5 | ESTRAMUSTINE PHOSPHATE SODIUM | 7 | 0.0233 |
| 6 | SODIUM MONOFLUOROPHOSPHATE | 7 | 0.0202 |
| 7 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 50 | 0.0184 |
| 8 | COAL TAR | 8 | 0.0160 |
| 9 | PAMIDRONATE DISODIUM | 45 | 0.0146 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1632 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 1359 |
| 2 | Corticosteroid [EPC] | 1311 |
| 3 | RANK Ligand Inhibitor [EPC] | 1032 |
| 4 | Benzodiazepine [EPC] | 925 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 676 |
| 6 | Provitamin D2 Compound [EPC] | 666 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 606 |
| 8 | Vitamin D [EPC] | 590 |
| 9 | Proton Pump Inhibitor [EPC] | 583 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lead Chelator [EPC] | 1 | 0.0156 |
| 1 | Complement 5a Receptor Antagonist [EPC] | 3 | 0.0069 |
| 2 | RANK Ligand Inhibitor [EPC] | 1032 | 0.0061 |
| 3 | Cytolytic Agent [EPC] | 10 | 0.0051 |
| 4 | Estrogen Receptor Antagonist [EPC] | 101 | 0.0046 |
| 5 | Interleukin-1 Receptor Antagonist [EPC] | 56 | 0.0046 |
| 6 | Prostacyclin Receptor Agonist [EPC] | 77 | 0.0042 |
| 7 | Interleukin-6 Receptor Antagonist [EPC] | 372 | 0.0041 |
| 8 | Thyroid Stimulating Hormone [EPC] | 3 | 0.0040 |
| 9 | Calcitonin [EPC] | 11 | 0.0039 |